dr. Martijn van Doorn

Medicine & Life Sciences

1. Chronic Urticaria 100%
2. Information Technology 59%
3. Cutaneous Mastocytosis 40%
4. Communication 38%
5. Skin 38%
6. Drug-Related Side Effects and Adverse Reactions 36%
7. Mastocytosis 34%
8. keyhole-limpet hemocyanin 34%
9. Gastrointestinal Agents 34%
10. Bullous Pemphigoid 32%
11. Delivery of Health Care 32%
12. Direct Fluorescent Antibody Technique 31%
13. Etanercept 31%
14. Sexual Health 29%
15. Drug Monitoring 28%
16. Delayed Hypersensitivity 28%
17. Patient Reported Outcome Measures 27%
18. Pandemics 26%
19. Immune System Diseases 26%
20. Adaptive Immunity 25%
21. Reproduction 24%
22. Confocal Microscopy 23%
23. Immunoglobulin G 22%
24. Melanoma 20%
25. Case-Control Studies 20%
26. Technology 19%
27. Immune System 19%
28. Systematic Reviews 18%
29. Randomized Controlled Trials 16%
30. Psoriasis 15%
31. Safety 14%
32. Injections 14%
33. Adalimumab 13%
34. Remote Consultation 12%
35. Pharmaceutical Preparations 12%
36. Urticaria 12%
37. Hypogonadism 11%
38. Reproductive Health 10%
39. Pregnancy Outcome 9%
40. Immunization 8%
41. Referral and Consultation 8%
42. Neoplasms 8%
43. Physicians 8%
44. Pressure 7%
45. Patient Care 6%
46. Fertility 5%
47. Acridine Orange 5%
48. Web Browser 5%
49. Spermatozoa 5%